FR2501197A1 - Complexes de platine-diamine, procede d'obtention, application therapeutique et compositions pharmaceutiques contenant un tel complexe - Google Patents
Complexes de platine-diamine, procede d'obtention, application therapeutique et compositions pharmaceutiques contenant un tel complexe Download PDFInfo
- Publication number
- FR2501197A1 FR2501197A1 FR8203450A FR8203450A FR2501197A1 FR 2501197 A1 FR2501197 A1 FR 2501197A1 FR 8203450 A FR8203450 A FR 8203450A FR 8203450 A FR8203450 A FR 8203450A FR 2501197 A1 FR2501197 A1 FR 2501197A1
- Authority
- FR
- France
- Prior art keywords
- group
- platinum
- substituted
- diamine
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 12
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000460 chlorine Substances 0.000 claims abstract description 9
- -1 HYDROXYL GROUP Chemical group 0.000 claims abstract description 7
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 6
- 150000007942 carboxylates Chemical class 0.000 claims abstract description 6
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910052740 iodine Chemical group 0.000 claims abstract description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims abstract description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims abstract description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical group OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 18
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 14
- 201000011510 cancer Diseases 0.000 claims description 9
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 3
- DDRVFRXYTKAZHH-UHFFFAOYSA-N 2-carboxyoxycarbonylbenzoic acid Chemical group OC(=O)OC(=O)C1=CC=CC=C1C(O)=O DDRVFRXYTKAZHH-UHFFFAOYSA-N 0.000 claims description 2
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical group OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims description 2
- 101150035983 str1 gene Proteins 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical group [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract description 2
- 229910021653 sulphate ion Inorganic materials 0.000 abstract description 2
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 231100001095 no nephrotoxicity Toxicity 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 241001331845 Equus asinus x caballus Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000417 nephrotoxicity Toxicity 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 1
- 229910020427 K2PtCl4 Inorganic materials 0.000 description 1
- 208000006552 Lewis Lung Carcinoma Diseases 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 description 1
- NDBYXKQCPYUOMI-UHFFFAOYSA-N platinum(4+) Chemical compound [Pt+4] NDBYXKQCPYUOMI-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- GGHDAUPFEBTORZ-UHFFFAOYSA-N propane-1,1-diamine Chemical compound CCC(N)N GGHDAUPFEBTORZ-UHFFFAOYSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8101026A NL8101026A (nl) | 1981-03-03 | 1981-03-03 | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2501197A1 true FR2501197A1 (fr) | 1982-09-10 |
| FR2501197B1 FR2501197B1 (enExample) | 1985-03-01 |
Family
ID=19837101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8203450A Granted FR2501197A1 (fr) | 1981-03-03 | 1982-03-02 | Complexes de platine-diamine, procede d'obtention, application therapeutique et compositions pharmaceutiques contenant un tel complexe |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4466924A (enExample) |
| JP (1) | JPS57163391A (enExample) |
| AT (1) | AT377252B (enExample) |
| AU (1) | AU559983B2 (enExample) |
| BE (1) | BE892330A (enExample) |
| CA (1) | CA1172647A (enExample) |
| CH (1) | CH649985A5 (enExample) |
| DE (1) | DE3207472A1 (enExample) |
| DK (1) | DK90382A (enExample) |
| FI (1) | FI71565C (enExample) |
| FR (1) | FR2501197A1 (enExample) |
| GB (1) | GB2093845B (enExample) |
| IE (1) | IE52626B1 (enExample) |
| IT (1) | IT1150608B (enExample) |
| LU (1) | LU83982A1 (enExample) |
| NL (1) | NL8101026A (enExample) |
| SE (1) | SE8201324L (enExample) |
| YU (1) | YU42457B (enExample) |
| ZA (1) | ZA821421B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59112995A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | ๆฐ่ฆใฐใชใณโใซ้ ธ็ฝ้้ฏไฝ |
| JPS59222498A (ja) * | 1983-06-01 | 1984-12-14 | Shionogi & Co Ltd | ๆฐ่ฆใฐใชใณโใซ้ ธ็ณป็ฝ้้ฏไฝใใใณๆๆชๆง่ ซ็ๅค |
| JPS6087295A (ja) * | 1983-10-19 | 1985-05-16 | Nippon Kayaku Co Ltd | ๆฐ่ฆ็ฝ้้ฏไฝ |
| US4599352A (en) * | 1984-03-01 | 1986-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Antineoplastic platinum (IV) complexes and compositions |
| US4562275A (en) * | 1984-03-23 | 1985-12-31 | Bristol-Myers Co. | Antitumor platinum complexes |
| US4550187A (en) * | 1984-04-12 | 1985-10-29 | The Research Foundation Of State University Of New York | Synthesis of platinum (IV) antineoplastic agents |
| HU193809B (en) * | 1984-09-12 | 1987-12-28 | Chugai Pharmaceutical Co Ltd | Process for producing new platinum complexes |
| US4739087A (en) * | 1985-01-10 | 1988-04-19 | Bristol-Myers Company | Antineoplastic platinum complexes |
| US4737589A (en) * | 1985-08-27 | 1988-04-12 | Nippon Kayaku Kabushiki Kaisha | Platinum Complexes |
| US4658047A (en) * | 1985-09-27 | 1987-04-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers |
| US5384127A (en) * | 1985-10-18 | 1995-01-24 | Board Of Regents, The University Of Texas System | Stable liposomal formulations of lipophilic platinum compounds |
| US5041581A (en) * | 1985-10-18 | 1991-08-20 | The University Of Texas System Board Of Regents | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| GB8525689D0 (en) * | 1985-10-18 | 1985-11-20 | Johnson Mathey Plc | Platinum coordination compounds |
| US5117022A (en) * | 1985-10-18 | 1992-05-26 | The Board Of Regents, The University Of Texas System | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| JPS62207283A (ja) * | 1986-03-07 | 1987-09-11 | Yoshinori Kitani | ๆฐ่ฆใช็ฝ้้ฏไฝ |
| US4716157A (en) * | 1986-03-20 | 1987-12-29 | American Cyanamid Company | Heterocyclic-1,2-diamine platinum complexes |
| JPS63203692A (ja) * | 1987-02-19 | 1988-08-23 | Nippon Kayaku Co Ltd | ๆฐ่ฆ็ฝ้้ฏไฝ |
| ATE113054T1 (de) * | 1988-02-02 | 1994-11-15 | Johnson Matthey Inc | Pt(iv) komplexe. |
| US5072011A (en) * | 1988-02-02 | 1991-12-10 | Johnson Matthey, Inc. | Pt(IV) complexes |
| US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| US5434256A (en) * | 1988-11-22 | 1995-07-18 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
| US5041578A (en) * | 1988-11-22 | 1991-08-20 | Board Of Regents, The University Of Texas System | Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents |
| US5196555A (en) * | 1989-10-17 | 1993-03-23 | Bristol-Myers Squibb Company | Water and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activity |
| US5843475A (en) * | 1996-12-06 | 1998-12-01 | Board Of Regents, The University Of Texas System | Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes |
| EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430406A1 (fr) * | 1978-07-06 | 1980-02-01 | Tno | Complexes platine-diamine, procede d'obtention, application d'un complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu |
| EP0008936A1 (en) * | 1978-09-02 | 1980-03-19 | Yoshinori Kidani | Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments |
| FR2473046A1 (fr) * | 1980-01-03 | 1981-07-10 | Tno | Complexes de platine (iv)-diamine et leur application comme medicament pour le traitement du cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1432562A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
| GB1578323A (en) * | 1976-02-26 | 1980-11-05 | Rustenburg Platinum Mines Ltd | Compositions containing platinum |
| US4182724A (en) * | 1976-04-06 | 1980-01-08 | Rustenburg Platinum Mines Limited | Compositions containing platinum |
| GB1585103A (en) * | 1976-04-06 | 1981-02-25 | Rustenburg Platinum Mines Ltd | Pharmaceutical compositions containing platinum compounds |
| US4137248A (en) * | 1977-08-29 | 1979-01-30 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof |
| SE7903359L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
| SE7903361L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
| NL189358C (nl) * | 1978-07-06 | 1993-03-16 | Tno | Werkwijze voor het bereiden van een geneesmiddel voor de behandeling van kanker, alsmede een van een 1,3-alkaandiamine afgeleid platina-diamminecomplex. |
-
1981
- 1981-03-03 NL NL8101026A patent/NL8101026A/nl not_active Application Discontinuation
-
1982
- 1982-02-26 US US06/352,538 patent/US4466924A/en not_active Expired - Fee Related
- 1982-03-02 AT AT0080182A patent/AT377252B/de not_active IP Right Cessation
- 1982-03-02 FR FR8203450A patent/FR2501197A1/fr active Granted
- 1982-03-02 CA CA000397440A patent/CA1172647A/en not_active Expired
- 1982-03-02 DE DE19823207472 patent/DE3207472A1/de not_active Ceased
- 1982-03-02 BE BE0/207447A patent/BE892330A/nl not_active IP Right Cessation
- 1982-03-02 CH CH1284/82A patent/CH649985A5/de not_active IP Right Cessation
- 1982-03-02 DK DK90382A patent/DK90382A/da not_active Application Discontinuation
- 1982-03-02 JP JP57031851A patent/JPS57163391A/ja active Granted
- 1982-03-02 FI FI820737A patent/FI71565C/fi not_active IP Right Cessation
- 1982-03-03 YU YU459/82A patent/YU42457B/xx unknown
- 1982-03-03 LU LU83982A patent/LU83982A1/de unknown
- 1982-03-03 IE IE480/82A patent/IE52626B1/en not_active IP Right Cessation
- 1982-03-03 ZA ZA821421A patent/ZA821421B/xx unknown
- 1982-03-03 GB GB8206228A patent/GB2093845B/en not_active Expired
- 1982-03-03 SE SE8201324A patent/SE8201324L/ not_active Application Discontinuation
- 1982-03-03 AU AU81091/82A patent/AU559983B2/en not_active Ceased
- 1982-03-03 IT IT19947/82A patent/IT1150608B/it active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2430406A1 (fr) * | 1978-07-06 | 1980-02-01 | Tno | Complexes platine-diamine, procede d'obtention, application d'un complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu |
| EP0008936A1 (en) * | 1978-09-02 | 1980-03-19 | Yoshinori Kidani | Platinum complexes, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments |
| FR2473046A1 (fr) * | 1980-01-03 | 1981-07-10 | Tno | Complexes de platine (iv)-diamine et leur application comme medicament pour le traitement du cancer |
Non-Patent Citations (3)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 87, no. 19, 7 novembre 1977, page 14, no. 145547q, Columbus Ohio (USA); * |
| JOURNAL OF CLINICAL HEMATOLOGY AND ONCOLOGY, vol. 7, no. 1, pages 114-37; * |
| JOURNAL OF CLINICAL HEMATOLOGY AND ONCOLOGY, vol. 7, no. 1, pages 231-41; * |
Also Published As
| Publication number | Publication date |
|---|---|
| BE892330A (nl) | 1982-09-02 |
| GB2093845B (en) | 1985-07-17 |
| AU559983B2 (en) | 1987-03-26 |
| FI71565C (fi) | 1987-01-19 |
| FI820737L (fi) | 1982-09-04 |
| CH649985A5 (de) | 1985-06-28 |
| ATA80182A (de) | 1984-07-15 |
| ZA821421B (en) | 1983-01-26 |
| YU42457B (en) | 1988-08-31 |
| IT8219947A0 (it) | 1982-03-03 |
| SE8201324L (sv) | 1982-09-04 |
| JPH0354117B2 (enExample) | 1991-08-19 |
| YU45982A (en) | 1985-06-30 |
| AU8109182A (en) | 1982-09-09 |
| NL8101026A (nl) | 1982-10-01 |
| US4466924A (en) | 1984-08-21 |
| FR2501197B1 (enExample) | 1985-03-01 |
| DE3207472A1 (de) | 1982-09-16 |
| JPS57163391A (en) | 1982-10-07 |
| AT377252B (de) | 1985-02-25 |
| GB2093845A (en) | 1982-09-08 |
| DK90382A (da) | 1982-09-04 |
| FI71565B (fi) | 1986-10-10 |
| IT1150608B (it) | 1986-12-17 |
| CA1172647A (en) | 1984-08-14 |
| IE52626B1 (en) | 1988-01-06 |
| IE820480L (en) | 1982-09-03 |
| LU83982A1 (de) | 1982-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2501197A1 (fr) | Complexes de platine-diamine, procede d'obtention, application therapeutique et compositions pharmaceutiques contenant un tel complexe | |
| FR2511685A1 (fr) | Complexe platine-diamine, procede d'obtention, application d'un tel complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu | |
| JP2710654B2 (ja) | ๏ผใ๏ผโใใน๏ผใขใใใกใใซ๏ผใทใฏใญใใฟใณโ็ฝ้้ฏๅๅ็ฉใใใฎ่ฃฝ้ ๆนๆณใ่ฉฒๅๅ็ฉใๅซๆใใๆ่ ซ็ไฝ็จใๆใใ่ฌๅคใใใณใใฎ่ฃฝ้ ๆนๆณ | |
| FR2473046A1 (fr) | Complexes de platine (iv)-diamine et leur application comme medicament pour le traitement du cancer | |
| JPWO1991009041A1 (ja) | ๆฐ่ฆ็ฝ้๏ผ๏ผ๏ผ้ฏไฝใใใณๆชๆง่ ซ็ๆฒป็ๅค | |
| FR2928151A1 (fr) | Derives platine-carbene n-heterocyclique, leur preparation et leur application en therapeutique | |
| CA2061759A1 (en) | Trans-pt (iv) complexes | |
| KR910002536B1 (ko) | ํ๋ผํฐ๋-๋์๋ฏผ ์ฐฉํ๋ฌผ์ ์ ์กฐ๋ฐฉ๋ฒ | |
| EP0513030A1 (en) | CIS-PLATINUM COMPLEXES WITH CHELATIVE AMINES AND SULFINYL CARBOXYLATES. | |
| EP0115929A1 (en) | Novel organic platinum complex and process for the preparation thereof | |
| US4739087A (en) | Antineoplastic platinum complexes | |
| JPS6137794A (ja) | ๆๆฉ็ฝ้้ฏไฝใใใณใใใๅซใๆ่ ซ็ๅค | |
| EP0210291A1 (en) | Platinum complexes of antitumor agents | |
| LU84365A1 (fr) | Complexes de platine-diamine,procede d'obtention,application d'un tel complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu | |
| FI76097B (fi) | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara platina-diaminkomplex. | |
| JPH0655752B2 (ja) | ็ฝ้็ฐ็ถใฆใฌใข้ฏไฝ | |
| FR2563524A1 (fr) | Complexes mixtes carboxylatoplatine (ii) et procede de preparation desdits complexes | |
| WO2003106469A1 (de) | Tumorhemmende platin(ii)-oxalato-komplexe | |
| US6458983B1 (en) | Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide-base modifiers | |
| DE60105057T2 (de) | Eine substanz oder eine zusammensetzung zur krebsbehandlung | |
| EP0262498A2 (de) | Diamin-platin (II)-Komplexverbindungen mit einem hydroxylierten 2-Phenyl-Indolring | |
| JPH02256690A (ja) | ๆฐ่ฆ็ฝ้้ฏไฝ | |
| FR2756289A1 (fr) | Nouveaux complexes du platine (ii) utiles comme agents anti-tumoraux | |
| JPH049393A (ja) | ๆฐ่ฆ็ฝ้้ฏไฝใใใณใใใๆๅนๆๅใจใใ่ ซ็ๆฒป็ๅค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |